StonvexLoading…
StonvexStonvexStonvexCore line items from PEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $374.76M | $1.02B | $663.60M | $324.14M |
Operating Income | $38.23M | $130.02M | $81.18M | $40.35M |
Net Income | $32.58M | $130.34M | $45.27M | $39.22M |
EPS (Diluted) | $0.82 | $3.32 | $2.15 | $1.00 |
Total Assets | $1.90B | $1.74B | $1.67B | $1.59B |
Total Liabilities | $424.63M | $385.67M | $380.86M | $380.43M |
Cash & Equivalents | $241.29M | $321.03M | $421.77M | $376.05M |
Free Cash Flow OCF − CapEx | $73.30M | $106.88M | $64.87M | $35.50M |
Shares Outstanding | 39.54M | 39.25M | 39.21M | 39.16M |